Increased 2025 guidance with expected net revenues of $818.0 million to $843.0 million, adjusted non-GAAP EBITDA of $213.0 million to $223.0 million, and adjusted non-GAAP diluted earnings per share ...

Detailed price information for Collegium Pharma (COLL-Q) from The Globe and Mail including charting and trades.

Q2 2025 Earnings Call Transcript August 7, 2025 Brilliant Earth Group, Inc. beats earnings expectations. Reported EPS is ...

Get key insights from ATN International's Q2 2025 earnings call, featuring a 15% dividend hike, fiber expansion, and reaffirmed 2025 guidance.

Calumet, Inc. (NASDAQ: CLMT) today reported results of Calumet, Inc. (the "Company," "Calumet," "we," "our" or "us") for the second quarter ended June 30, 2025, as follows: ...

American Healthcare REIT, Inc. (the "Company," "we," "our," "management," or "us") (NYSE: AHR) announced today its second quarter 2025 results and is increasing full year 2025 guidance. Key Highlights ...

Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital i ...

Cipher Mining Inc. ( NASDAQ: CIFR) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Courtney Knight - Head of Investor Relations Edward John Farrell - Chief Financial Officer Rodney Tyler ...

Key Points GAAP earnings per share from net investment income was $0.32 for Q2 2025, but Adjusted net investment income (non-GAAP) and GAAP revenue for Q2 2025 both missed analyst estimates.

PLANO, TX / ACCESS Newswire / August 6, 2025 / BGSF, Inc. (NYSE:BGSF), a leading provider of workforce solutions through the ...

Management Board of Northern Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund (the Fund) for the six months of 2025. Challenges in Executing our Strategy Our ...